HDAX P-IN./ DE0008469016
HDAX23/08/2024 17:50:00 | Chg. +78.37 | Open | High | Low | Previous Close |
---|---|---|---|---|---|
9,832.54XXP | +0.80% | 9,776.03 | 9,847.55 | 9,769.72 | 9,754.17 |
GlobeNewswire
13/12/2016
MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or...
GlobeNewswire
06/12/2016
MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 201...
GlobeNewswire
06/12/2016
MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016
GlobeNewswire
29/11/2016
MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire
28/11/2016
MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application Fo...
GlobeNewswire
25/11/2016
MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire
22/11/2016
Correction of a release from 21.11.2016, 18:05 CET - MorphoSys AG: Publication pursuant to §26 sect....
GlobeNewswire
21/11/2016
MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...
GlobeNewswire
21/11/2016
MorphoSys AG: Notification of managers`transactions according to article 19 MAR
GlobeNewswire
21/11/2016
MorphoSys AG: Notification of managers`transactions according to article 19 MAR
GlobeNewswire
17/11/2016
MorphoSys Announces That Its Licensee Janssen Has Submitted Biologics License Application For Guselk...
GlobeNewswire
17/11/2016
MorphoSys AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of...
GlobeNewswire
15/11/2016
MorphoSys Announces That Its Licensee Janssen Has Presented Positive Clinical Data of Guselkumab in ...
GlobeNewswire
08/11/2016
Anke Linnartz joins MorphoSys as Head of Corporate Communications and Investor Relations
GlobeNewswire
03/11/2016
MorphoSys Announces Presentations of Clinical Data at Upcoming American Society of Hematology (ASH) ...
GlobeNewswire
02/11/2016
MorphoSys and LEO Pharma Enter into Strategic Alliance to Develop Therapeutic Antibodies in Dermatol...
GlobeNewswire
20/10/2016
MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial with Novel Cancer Antibody